Literature DB >> 1802026

Suppressive effect by melatonin on different phases of 9,10-dimethyl-1,2-benzanthracene (DMBA)-induced rat mammary gland carcinogenesis.

A Subramanian1, L Kothari.   

Abstract

This comprehensive study examines the influence of oral melatonin on the initiation and promotion phases of DMBA-induced mammary tumorigenesis in intact and pinealectomized female Holtzman rats reared in short (light:dark schedule L:D 10:14) and long (L:D 24:0) photoperiods. Melatonin administration in the initiation phase significantly suppressed tumor incidence only in intact animals reared in both photoperiods, indicating that the presence of the pineal was obligatory. On the other hand, during the promotion phase, irrespective of the presence or absence of the pineal, the tumor-suppressive effect of exogenous melatonin was pronounced.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1802026     DOI: 10.1097/00001813-199106000-00013

Source DB:  PubMed          Journal:  Anticancer Drugs        ISSN: 0959-4973            Impact factor:   2.248


  3 in total

1.  Preventive and curative effect of melatonin on mammary carcinogenesis induced by dimethylbenz[a]anthracene in the female Sprague-Dawley rat.

Authors:  Véronique Lenoir; Marianne Beau Yon de Jonage-Canonico; Marie-Hélène Perrin; Antoine Martin; Robert Scholler; Bernard Kerdelhué
Journal:  Breast Cancer Res       Date:  2005-04-29       Impact factor: 6.466

2.  Melatonin blocks the stimulatory effects of prolactin on human breast cancer cell growth in culture.

Authors:  A Lemus-Wilson; P A Kelly; D E Blask
Journal:  Br J Cancer       Date:  1995-12       Impact factor: 7.640

Review 3.  Melatonin: A Molecule for Reducing Breast Cancer Risk.

Authors:  Alicia González-González; María Dolores Mediavilla; Emilio J Sánchez-Barceló
Journal:  Molecules       Date:  2018-02-06       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.